IPOPI (International Patient Organisation for Primary Immunodeficiencies)

Noticias de International Patient Organisation for Primary Immunodeficiencies

Improving PID patients’ lives. Worldwide. 
IPOPI
  1. Among this year’s outstanding abstracts, three winners were selected to receive special recognition at IPIC2025, with a certificate, a grant, and the opportunity to present their work during a dedicated session. We congratulate Dr Inês Serra on achieving 1st place with her work, “Analysis of Genetic Overlap Between Inborn Errors of Immunity and Neurodevelopmental Disorders.” Her […]

    The post Meet Dr Inês Serra: 1st Place Poster Winner at IPIC2025 first appeared on IPOPI.

  2. We extend our heartfelt thanks to everyone who made IPIC2025 an unforgettable success! With over 900 attendees, IPIC2025 was a truly inspiring gathering of our global community—filled with learning, collaboration, and shared commitment to advancing care for people with primary immunodeficiencies. As we close this remarkable chapter, we are already looking ahead with excitement to our […]

    The post Thank You and See You in Mallorca! first appeared on IPOPI.

  3. IPOPI has welcomed the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). The opinion recommends granting marketing authorisation in the European Union for Waskyra™, a groundbreaking ex vivo gene therapy for Wiskott-Aldrich Syndrome (WAS), a rare and life-threatening primary immunodeficiency. “This marks a significant milestone […]

    The post IPOPI Applauds EMA’s Positive Opinion on Waskyra™ for Wiskott-Aldrich Syndrome first appeared on IPOPI.

  4. In 2024, IPOPI continued to bring the global PID community together — connecting patients, experts, and advocates across 75 countries to improve lives and drive progress in care and diagnosis for people with primary immunodeficiencies (PIDs). Highlights included the XVIII Global Patients’ Meeting in Marseille, new advocacy initiatives on plasma access and newborn screening, and […]

    The post IPOPI’s 2024 Review of Activities and Achievements first appeared on IPOPI.

  5. The IPOPI Jose Drabwell Research Grant Programme is an initiative aimed at promoting scientific and clinical research in the field of primary immunodeficiencies. The second grant call in 2025, supported by Grifols and Kedrion, ran from April to August, inviting applicants from around the world to seize the opportunity to fuel innovation in the field […]

    The post The IPOPI Jose Drabwell Research Grant Programme Winners first appeared on IPOPI.

Este sitio web utiliza cookies
Para ofrecer las mejores experiencias, utilizamos tecnologías como las cookies para almacenar y/o acceder a la información del dispositivo. El consentimiento de estas tecnologías nos permitirá procesar datos como el comportamiento de navegación o las identificaciones únicas en este sitio. No consentir o retirar el consentimiento, puede afectar negativamente a ciertas características y funciones. Puede aceptarlas y continuar o seleccionar las que desea cargar y pulsar en guardar preferencias.